Market Dashboard
Sensex Breaks Two-Day Rising Streak, Nifty Settles At 10,767. 10 Points To Know
By NDTV
on 08 Jun 2018 | 04:11 PM
NSE Symbol: | BSE Code: | ISIN: | Sector:
- Add to Portfolio
- Add to Watchlist
- Add to Alert
Add to Portfolio
NSE
1235.80
| Change | Change % |
| -3.50 | -0.28% |
Updated:08 Dec, 2023, 15:57 PM IST |
|
BSE
1235.50
| Change | Change % |
| -4.25 | -0.34% |
Updated:08 Dec, 2023, 16:01 PM IST |
|
Sun Pharma Inds.'s Latest News
Sensex Falls On North Korea Tensions; Pharma, Metal Shares Under Pressure
By NDTV
on 15 Sep 2017 | 01:59 PM
Sensex Edges Higher; Pharma, Banking Shares Lead Gains
By NDTV
on 14 Sep 2017 | 01:41 PM
Sensex Eases From Record Highs; Reliance Communications Hits Life Low
By NDTV
on 29 May 2017 | 01:29 PM
Aurobindo Pharma Shares Hit 9-Month Low On US Price Fixing Lawsuit
By NDTV
on 16 Dec 2016 | 11:00 AM
Sun Pharma First-Quarter Profit Boosted By Gleevec Generic
By NDTV
on 12 Aug 2016 | 03:29 PM
Sun Pharma Launches Cancer Drug In Europe, Shares Gain
By NDTV
on 11 Jul 2016 | 11:18 AM
Sun Pharma Fourth Quarter Profit Almost Doubles But Misses Estimates
By NDTV
on 31 May 2016 | 09:45 AM
Sun Pharma Gets US Subpoena Over Generic Drugs Pricing
By NDTV
on 29 May 2016 | 08:26 PM
Sun Pharma Slumps After US Issues New Reprimand to India Drug Industry
By NDTV
on 21 Dec 2015 | 12:36 PM
Sun Pharma Inds.'s Recent video coverage
Sun Pharma Inds.'s Announcements
By NSE on 16 Aug 2018 | 00:00 AM
Sun Pharmaceutical Industries Limited has informed the Exchange regarding a press release dated August 16, 2018, titled "Sun Pharma Announces U.S. FDA...
Announcement under Regulation 30 (LODR)-Press Release / Media Release
By BSE on 25 Jul 2018 | 13:03 PM
We are pleased to enclose herewith our Press Release relating to launch of Generic Glumetza? Tablets in US, which we shall be releasing after sending ...
By NSE on 25 Jul 2018 | 00:00 AM
Sun Pharmaceutical Industries Limited has informed the Exchange regarding a press release dated July 25, 2018, titled "Sun Pharma Announces Launch of ...
Statement Of Investor Complaints For The Quarter Ended June 2018
By BSE on 18 Jul 2018 | 15:13 PM
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disp...
Announcement under Regulation 30 (LODR)-Press Release / Media Release
By BSE on 18 Jul 2018 | 11:11 AM
We are pleased to enclose herewith our Press Release relating to US FDA Approval of INFUGEM Injection, which we shall be releasing after sending this ...
By NSE on 18 Jul 2018 | 00:00 AM
Sun Pharmaceutical Industries Limited has informed the Exchange regarding a press release dated July 18, 2018, titled "Sun Pharma Announces U.S. FDA A...
By NSE on 18 Jul 2018 | 00:00 AM
Sun Pharmaceutical Industries Limited has informed the Exchange regarding a press release dated July 18, 2018, titled "Sun Pharma Announces U.S. FDA A...
By NSE on 12 Jul 2018 | 00:00 AM
SUNPHARMA:The Exchange has sought clarification from Sun Pharmaceutical Industries Limited with respect to announcement dated 11-Jul-2018, regarding "...
By NSE on 12 Jul 2018 | 00:00 AM
Sun Pharmaceutical Industries Limited has informed the Exchange regarding 'Submission of Advertisement published in newspapers regarding Notice for tr...
By NSE on 12 Jul 2018 | 00:00 AM
SUNPHARMA:The Exchange had sought clarification from Sun Pharmaceutical Industries Limited with respect to announcement dated 11-Jul-2018, regarding "...
By NSE on 11 Jul 2018 | 00:00 AM
Sun Pharmaceutical Industries Limited has informed the Exchange regarding a press release dated July 11, 2018, titled "DUSA Pharmaceuticals, Inc. file...
Announcement under Regulation 30 (LODR)-Press Release / Media Release
By BSE on 09 Jul 2018 | 14:39 PM
Sun Pharma signs Akshay Kumar as Revital H Brand Ambassador.
By NSE on 09 Jul 2018 | 00:00 AM
Sun Pharmaceutical Industries Limited has informed the Exchange regarding a press release dated July 09, 2018, titled "Sun Pharma signs Akshay Kumar a...
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
By BSE on 06 Jul 2018 | 10:27 AM
The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 fo...
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
By BSE on 27 Jun 2018 | 16:01 PM
The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 fo...
By NSE on 12 Jun 2018 | 00:00 AM
Sun Pharmaceutical Industries Limited has informed the Exchange regarding a press release dated Jun 12, 2018, titled "Sun Pharma receives EIR for Halo...
Clarification sought from Sun Pharmaceutical Industries Ltd
By BSE on 08 Jun 2018 | 16:55 PM
The Exchange has sought clarification from Sun Pharmaceutical Industries Ltd on June 08, 2018 with reference to news appeared on : www.moneycontrol.co...
By NSE on 08 Jun 2018 | 00:00 AM
The Exchange has sought clarification from Sun Pharmaceutical Industries Limited with respect to recent news item captioned "No re-inspection at Sun P...
By NSE on 05 Jun 2018 | 00:00 AM
Sun Pharmaceutical Industries Limited has informed the Exchange regarding a press release dated Jun 05, 2018, titled "Sun Pharma receives prestigious ...
By BSE on 01 Jun 2018 | 15:02 PM
Proceedings of National Company Law Tribunal convened separate meetings of the equity shareholders and unsecured creditors of Sun Pharmaceutical Indus...